Newsbrief

Expertly Curated Sterilization and Infection Control News
 

Hospital

Ted May Beyond Clean Expert Series

Ted May: Beyond Clean Expert Series

Every month, Andersen’s Ted May will explore topics like safety, history, emissions and even molecular science related to medical device gas sterilization. These articles are published as part of Beyond Clean’s “Expert Series”—articles written by medical experts tackling some of the most pressing issues facing Sterile Processing departments. This month: Is Liquid Chemical Sterilization Efficacy the Same as Ethylene Oxide Sterilization? MORE…

Beyond Clean Expert Series Conference

An intensely honest conversation about ethylene oxide sterilization

Is ethylene oxide (EO or EtO) more toxic than hydrogen peroxide? What are the most prevalent myths about EO in the industry today? What does the future of EO look like?

Andersen’s President and CEO, A.E. (Ted) May joined Beyond Clean’s Justin Poulin for an intensely honest conversation about gas sterilization. In typical Beyond Clean fashion, Poulin asked the tough questions regarding the history surrounding EO and its role in the future of hospital sterile processing departments, specifically around duodenoscope and endoscope reprocessing. LEARN MORE…

NCBiotech story

Andersen Sterilizers: A NC Company with a Global Impact

Andersen’s innovation, affordability and customer service is earning headlines! North Carolina Biotechnology Center wrote an article “Andersen Sterilizers: An NC Company with a Global Impact” published this morning. Learn more about Andersen:

  • Earning FDA’s first 510k clearance for terminal sterilization of duodenoscopes
  • Winning awards for its Zero Emission technology
  • Serving as a critical sterilization solution for the Life Sciences Industry

LEARN MORE…

FDA investigates reports of urological endoscope infections

FDA investigates urological endoscopes

The Food and Drug Administration (FDA) announced it is investigating reports of infections associated with reprocessed urological endoscopes. The FDA received more than 450 medical device reports (MDRs) describing post-procedure patient infections or other contamination issues associated with reprocessing urological endoscopes. Andersen’s EOGas 4 presents an FDA-cleared terminal sterilization option for the urological endoscopes under investigation, as well as significantly longer and smaller diameter scopes.

Newsbrief NCBioTech Header

Andersen Partners with North Carolina Biotechnology Center to Advance Life Sciences Industry

Andersen recently welcomed leadership from North Carolina Biotechnology Center (NCBiotech) to tour its manufacturing campus in Haw River, NC, and industrial sterilization sister company, Andersen Scientific in Morrisville, NC. Andersen works with NCBiotech to provide critical sterilization resources for start-ups, R&D departments and companies developing strategies to bring devices to market in North Carolina. MORE…

Beyond Clean Podcast EOGas 4 510(k) Clearance

Beyond Clean Podcast: FDA’s First 510(k) Clearance for Terminal Sterilization of Duodenoscopes

Andersen’s EOGas 4 is the first, and only, sterilization system FDA 510k cleared for terminal sterilization of duodenoscopes and colonoscopes. A true game changer for healthcare facilities that sterilize these critical instruments. On a recent Beyond Clean podcast, Ted May, Andersen President and CEO, and Dr. Larry Muscarella of LFM Healthcare Solutions LLC, take you inside the science behind this one-of-a-kind sterilization technology proven to sterilize the toughest endoscopes on the market. MORE…

Scroll to Top